Oct. 22 at 2:46 PM
$CRMD $DVA $FMS
While every other provider protects patients, DaVita chooses to ignore DefenCath, the therapy proven to prevent deadly infections and costly hospitalizations. This isn’t caution or strategy, it’s negligence dressed as cost control. The market sees it, regulators see it, and patients feel it. When the fallout hits, it won’t be measured in dollars, it will be measured in lives.
